Clinical Trial Update: A Study to Evaluate the Efficacy of Paliperidone Palmitate in the Prevention of Relapse of the Symptoms of Schizoaffective Disorder [Phase 3]

View source ↗

Summary

Phase 3 study evaluating paliperidone palmitate for relapse prevention in schizoaffective disorder has completed, with results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder

Drugs mentioned

• INVEGA SUSTENNA (PALIPERIDONE PALMITATE)

Snippet

Sponsor: Janssen Scientific Affairs, LLC | Conditions: Schizoaffective Disorder | Phase 3 | Status: COMPLETED | Results posted: 2015-01-05